NSE:LYKALABS - Lyka Labs Stock Price & Analysis

About Lyka Labs (NSE:LYKALABS)

(NSE:LYKALABS) Lyka Labs Limited engages in manufacturing pharmaceutical formulations and active pharmaceutical ingredients various therapeutic segments in India. It manufactures and sells various formulations, including emollient, topical steroid, antifungal agent, topical anti-bacterial, acne management, dermatological formulation, pain killer, anti-aging, cleansing lotion, hair care, anti-dandruff shampoo, sunscreen, anti-acne, cosmeceutical, anti-oxidant, proton pump inhibitor, anti-malarial, anti-bacterial, corticosteroid hormones, cephalosporin, dry powder injection, muscle relaxant, bone resorption inhibitor, anti-oxidant/liver disease, antibiotic, and lyophilized products. The company also provides contracted manufacturing services to various large pharmaceutical companies; and medical and technical assistance in the areas of manufacturing know how and manufacturing facilities, as well as technical data, such as molecule stability testing data, impurity profile, BA/BE clinical study data, etc. In addition, it provides products and services in therapeutic categories, such as intensive care, gastroenterology, anti-infective, anti-fungal, surgery care, cosmetologist, urology, wound care, and anesthesia, as well as deals in pharmaceutical products. Lyka Labs Limited offers its products in various formulations, including injections, creams, ointments, foams, gels, and lotions. Further, the company exports its products to Bangladesh, Combodia, Congo, Costa Rica, Peru, Romania, Russia, Sri Lanka, Sudan, Ukraine, Venezuela, and Vietnam. Lyka Labs Limited was incorporated in 1976 and is based in Mumbai, India.

LYKALABS Stock Price

Statistics Highlights (NSE:LYKALABS)

Shares Outstanding	28.69M	Beta	1.32
Public Float	15.59M	P/E Ratio	8.06
% Short of Float	-	Dividend (Yield)	-
Held by Insiders	54.25%	Ex-Dividend Date
Held by Institutions	-	IPO Date	-

Explore More on "Statistics" Section

LYKALABS Financial Summary

|

	Mar 21	Mar 20	Mar 19
Revenue	INR671.07M	INR554.08M	INR642.38M
EBITDA	INR183.70M	INR-101.35M	INR-17.59M
Net Income	INR-115.55M	INR-605.41M	INR-55.50M
Total Assets	INR1.90B	INR2.00B	INR2.17B
Total Cash	INR2.36M	INR1.79M	INR-2.83M
Total Debt	INR1.63B	INR1.44B	INR976.41M

	Dec 21	Sep 21	Jun 21
Revenue	INR355.74M	INR738.89M	INR494.37M
EBITDA	INR136.03M	INR431.80M	INR304.37M
Net Income	INR60.86M	INR284.33M	INR195.51M
Total Assets	INR	INR1.98B	INR
Total Cash	INR	INR111.99M	INR
Total Debt	INR	INR1.25B	INR

LYKALABS Stock Price History

Lyka Labs Annual Stock Price History

Year	Open	Close	Change
2021	INR216.00	INR182.30	-15.60%
2021	INR32.55	INR216.00	563.59%
2020	INR19.25	INR32.55	69.09%

Lyka Labs Daily Stock Price History

Date	Open	High	Low	Close	Change	Volume
Jun 17, 2022	INR116.00	INR119.00	INR114.00	INR116.65	-6.61%	69.55K
Jun 14, 2022	INR125.85	INR128.30	INR124.10	INR124.90	-0.24%	182.24K
Jun 9, 2022	INR120.60	INR127.45	INR120.10	INR125.20	7.38%	111.70K

View More on "Price History" Section

(NSE:LYKALABS) Stock Price FAQs

What is today's stock price of Lyka Labs (NSE:LYKALABS)?

The current stock price of Lyka Labs (NSE:LYKALABS) is INR182.30.
Today LYKALABS stock price opened at INR175.00 after previous close of INR173.65.
During the day, Lyka Labs stock quote has varied from a low of INR175.00 to a high of INR182.30.

What is Lyka Labs's 52-week change?

LYKALABS 52-week high stock quote is INR267.00, which is 46.50% above the current share price.
The Lyka Labs (NSE:LYKALABS) 52-week low stock price is INR41.00, which is 77.50% below the current share price.
Lyka Labs share price volatility (52-week beta) is 1.32.

Lyka Labs (NSE:LYKALABS) FAQ

How Much is Lyka labs Worth?

Lyka labs's worth today based on market capitalisation is INR4.42B

How much dividend does Lyka labs Pay?

The current annualized dividend payout for LYKALABS stock is INR0.00, the dividend yield is 0.00% and the payout ratio is 0.00%.
View More Details on Lyka labs's "Dividend" Section

What is Lyka labs’s Price to Earning (PE) ratio?

Lyka labs has a Price to Earning (P/E) ratio of 8.06. LYKALABS stock also has a Price to Sales (P/S) ratio of 2.67.

What is the Lyka labs's ticker?

Lyka labs trades on the NSE stock market in India under the ticker symbol "LYKALABS". Lyka labs’s stock symbol can also be displayed as "NSE:LYKALABS".

Who are the owners of Lyka labs?

Lyka labs (NSE:LYKALABS) is owned by 0.00% institutional shareholders and by 54.25% insiders. The rest is owned by the public.
Explore More Details on Lyka labs's “Ownership” Section

Who are the key executives of Lyka labs (LYKALABS)?

Lyka labs's key executive team includes the following managers:

Mr. Kunal Narendra Gandhi, Chairman, MD & CEO (1987)
Mr. Yogesh Babulal Shah, CFO & Exec. Director (1960)
Mr. Piyush Girishchandra Hindia, Company Sec. & Compliance Officer (NA)
Mr. B. S. Arun Rao, CEO of Lyka BDR International Ltd and Whole-Time Director of Lyka BDR International Ltd (NA)

What is Lyka labs’s Sector & Industry Classification?

Lyka labs (NSE:LYKALABS) is classified under the "Healthcare" sector and under the "Biotechnology" industry.

How many employees work for Lyka labs?

Currently the number of employees working for Lyka labs is 99.

Where are Lyka labs's Headquarters?

Lyka labs (NSE:LYKALABS) is headquartered in India.

What are Lyka labs's Address and Phone Number?

Lyka labs’s mailing address is Spencer Building, Mumbai, India, 400036.
The company’s phone number is 91 22 6611 2200.

What is the official website for Lyka labs?

Lyka labs’s official website is http://www.lykalabs.com

Lyka Labs Stock (NSE:LYKALABS)